癌症护理连续性的患者导航:系统综述和新兴文献综述。

IF 503.1 1区 医学 Q1 ONCOLOGY CA: A Cancer Journal for Clinicians Pub Date : 2023-06-26 DOI:10.3322/caac.21788
Raymond J. Chan RN, PhD, Vivienne E. Milch MBBS(Hons), MHPol, Fiona Crawford-Williams PhD, Oluwaseyifunmi Andi Agbejule BRadTherapy, Ria Joseph MNutrDiet, Jolyn Johal BND(Hons), Narayanee Dick BSc(Hons), Matthew P. Wallen PhD, Julie Ratcliffe PhD, Anupriya Agarwal MBBS, Larissa Nekhlyudov MD, Matthew Tieu PhD, Manaf Al-Momani BPharm, Scott Turnbull PhD, Rahul Sathiaraj MPH, Dorothy Keefe MBBS, MD, Nicolas H. Hart PhD
{"title":"癌症护理连续性的患者导航:系统综述和新兴文献综述。","authors":"Raymond J. Chan RN, PhD,&nbsp;Vivienne E. Milch MBBS(Hons), MHPol,&nbsp;Fiona Crawford-Williams PhD,&nbsp;Oluwaseyifunmi Andi Agbejule BRadTherapy,&nbsp;Ria Joseph MNutrDiet,&nbsp;Jolyn Johal BND(Hons),&nbsp;Narayanee Dick BSc(Hons),&nbsp;Matthew P. Wallen PhD,&nbsp;Julie Ratcliffe PhD,&nbsp;Anupriya Agarwal MBBS,&nbsp;Larissa Nekhlyudov MD,&nbsp;Matthew Tieu PhD,&nbsp;Manaf Al-Momani BPharm,&nbsp;Scott Turnbull PhD,&nbsp;Rahul Sathiaraj MPH,&nbsp;Dorothy Keefe MBBS, MD,&nbsp;Nicolas H. Hart PhD","doi":"10.3322/caac.21788","DOIUrl":null,"url":null,"abstract":"<p>Patient navigation is a strategy for overcoming barriers to reduce disparities and to improve access and outcomes. The aim of this umbrella review was to identify, critically appraise, synthesize, and present the best available evidence to inform policy and planning regarding patient navigation across the cancer continuum. Systematic reviews examining navigation in cancer care were identified in the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase, Cumulative Index of Nursing and Allied Health (CINAHL), Epistemonikos, and Prospective Register of Systematic Reviews (PROSPERO) databases and in the gray literature from January 1, 2012, to April 19, 2022. Data were screened, extracted, and appraised independently by two authors. The JBI Critical Appraisal Checklist for Systematic Review and Research Syntheses was used for quality appraisal. Emerging literature up to May 25, 2022, was also explored to capture primary research published beyond the coverage of included systematic reviews. Of the 2062 unique records identified, 61 systematic reviews were included. Fifty-four reviews were quantitative or mixed-methods reviews, reporting on the effectiveness of cancer patient navigation, including 12 reviews reporting costs or cost-effectiveness outcomes. Seven qualitative reviews explored navigation needs, barriers, and experiences. In addition, 53 primary studies published since 2021 were included. Patient navigation is effective in improving participation in cancer screening and reducing the time from screening to diagnosis and from diagnosis to treatment initiation. Emerging evidence suggests that patient navigation improves quality of life and patient satisfaction with care in the survivorship phase and reduces hospital readmission in the active treatment and survivorship care phases. Palliative care data were extremely limited. Economic evaluations from the United States suggest the potential cost-effectiveness of navigation in screening programs.</p>","PeriodicalId":137,"journal":{"name":"CA: A Cancer Journal for Clinicians","volume":null,"pages":null},"PeriodicalIF":503.1000,"publicationDate":"2023-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"8","resultStr":"{\"title\":\"Patient navigation across the cancer care continuum: An overview of systematic reviews and emerging literature\",\"authors\":\"Raymond J. Chan RN, PhD,&nbsp;Vivienne E. Milch MBBS(Hons), MHPol,&nbsp;Fiona Crawford-Williams PhD,&nbsp;Oluwaseyifunmi Andi Agbejule BRadTherapy,&nbsp;Ria Joseph MNutrDiet,&nbsp;Jolyn Johal BND(Hons),&nbsp;Narayanee Dick BSc(Hons),&nbsp;Matthew P. Wallen PhD,&nbsp;Julie Ratcliffe PhD,&nbsp;Anupriya Agarwal MBBS,&nbsp;Larissa Nekhlyudov MD,&nbsp;Matthew Tieu PhD,&nbsp;Manaf Al-Momani BPharm,&nbsp;Scott Turnbull PhD,&nbsp;Rahul Sathiaraj MPH,&nbsp;Dorothy Keefe MBBS, MD,&nbsp;Nicolas H. Hart PhD\",\"doi\":\"10.3322/caac.21788\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Patient navigation is a strategy for overcoming barriers to reduce disparities and to improve access and outcomes. The aim of this umbrella review was to identify, critically appraise, synthesize, and present the best available evidence to inform policy and planning regarding patient navigation across the cancer continuum. Systematic reviews examining navigation in cancer care were identified in the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase, Cumulative Index of Nursing and Allied Health (CINAHL), Epistemonikos, and Prospective Register of Systematic Reviews (PROSPERO) databases and in the gray literature from January 1, 2012, to April 19, 2022. Data were screened, extracted, and appraised independently by two authors. The JBI Critical Appraisal Checklist for Systematic Review and Research Syntheses was used for quality appraisal. Emerging literature up to May 25, 2022, was also explored to capture primary research published beyond the coverage of included systematic reviews. Of the 2062 unique records identified, 61 systematic reviews were included. Fifty-four reviews were quantitative or mixed-methods reviews, reporting on the effectiveness of cancer patient navigation, including 12 reviews reporting costs or cost-effectiveness outcomes. Seven qualitative reviews explored navigation needs, barriers, and experiences. In addition, 53 primary studies published since 2021 were included. Patient navigation is effective in improving participation in cancer screening and reducing the time from screening to diagnosis and from diagnosis to treatment initiation. Emerging evidence suggests that patient navigation improves quality of life and patient satisfaction with care in the survivorship phase and reduces hospital readmission in the active treatment and survivorship care phases. Palliative care data were extremely limited. Economic evaluations from the United States suggest the potential cost-effectiveness of navigation in screening programs.</p>\",\"PeriodicalId\":137,\"journal\":{\"name\":\"CA: A Cancer Journal for Clinicians\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":503.1000,\"publicationDate\":\"2023-06-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"8\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"CA: A Cancer Journal for Clinicians\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.3322/caac.21788\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"CA: A Cancer Journal for Clinicians","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.3322/caac.21788","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 8

摘要

患者导航是一种克服障碍、减少差异、改善获取和结果的策略。这项总括性审查的目的是识别、批判性评估、综合和提供最佳可用证据,为癌症患者导航的政策和规划提供信息。2012年1月1日至2022年4月19日,在Cochrane中央对照试验注册中心(Central)、PubMed、Embase、护理和联合健康累积指数(CINAHL)、Epistemonikos和前瞻性系统评价注册中心(PROSPERO)数据库和灰色文献中确定了检查癌症治疗导航的系统评价。数据由两位作者独立筛选、提取和评估。JBI系统评审和研究综合关键评估检查表用于质量评估。截至2022年5月25日的新兴文献也进行了探索,以获取在纳入系统综述范围之外发表的初步研究。在确定的2062个独特记录中,包括61个系统审查。50篇综述是定量或混合方法综述,报告癌症患者导航的有效性,包括12篇报告成本或成本效益结果的综述。七项定性审查探讨了导航需求、障碍和经验。此外,还包括自2021年以来发表的53项初级研究。患者导航可有效提高癌症筛查的参与度,缩短从筛查到诊断以及从诊断到治疗开始的时间。新出现的证据表明,患者导航在生存期提高了生活质量和患者对护理的满意度,并在积极治疗和生存期护理阶段减少了再次入院。姑息治疗数据极其有限。来自美国的经济评估表明,导航在筛查项目中具有潜在的成本效益。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Patient navigation across the cancer care continuum: An overview of systematic reviews and emerging literature

Patient navigation is a strategy for overcoming barriers to reduce disparities and to improve access and outcomes. The aim of this umbrella review was to identify, critically appraise, synthesize, and present the best available evidence to inform policy and planning regarding patient navigation across the cancer continuum. Systematic reviews examining navigation in cancer care were identified in the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase, Cumulative Index of Nursing and Allied Health (CINAHL), Epistemonikos, and Prospective Register of Systematic Reviews (PROSPERO) databases and in the gray literature from January 1, 2012, to April 19, 2022. Data were screened, extracted, and appraised independently by two authors. The JBI Critical Appraisal Checklist for Systematic Review and Research Syntheses was used for quality appraisal. Emerging literature up to May 25, 2022, was also explored to capture primary research published beyond the coverage of included systematic reviews. Of the 2062 unique records identified, 61 systematic reviews were included. Fifty-four reviews were quantitative or mixed-methods reviews, reporting on the effectiveness of cancer patient navigation, including 12 reviews reporting costs or cost-effectiveness outcomes. Seven qualitative reviews explored navigation needs, barriers, and experiences. In addition, 53 primary studies published since 2021 were included. Patient navigation is effective in improving participation in cancer screening and reducing the time from screening to diagnosis and from diagnosis to treatment initiation. Emerging evidence suggests that patient navigation improves quality of life and patient satisfaction with care in the survivorship phase and reduces hospital readmission in the active treatment and survivorship care phases. Palliative care data were extremely limited. Economic evaluations from the United States suggest the potential cost-effectiveness of navigation in screening programs.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
873.20
自引率
0.10%
发文量
51
审稿时长
1 months
期刊介绍: CA: A Cancer Journal for Clinicians" has been published by the American Cancer Society since 1950, making it one of the oldest peer-reviewed journals in oncology. It maintains the highest impact factor among all ISI-ranked journals. The journal effectively reaches a broad and diverse audience of health professionals, offering a unique platform to disseminate information on cancer prevention, early detection, various treatment modalities, palliative care, advocacy matters, quality-of-life topics, and more. As the premier journal of the American Cancer Society, it publishes mission-driven content that significantly influences patient care.
期刊最新文献
Breast cancer statistics 2024. Breast cancer: The good, the bad, and an important call to effective risk reduction strategies. Reviewer acknowledgement 2024 Issue Information Cancer disparities for LGBTQ+ patients identified more fully
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1